Carpio Robert L III 4
4 · WATERS CORP /DE/ · Filed Feb 27, 2026
Research Summary
AI-generated summary of this filing
Waters SVP Robert Carpio Receives Stock Awards (RSUs & Options)
What Happened
- Robert L. Carpio III, Senior Vice President, Waters Analytical Sciences at Waters Corporation (WAT), received stock awards on February 25, 2026: 997 restricted stock units (RSUs) and a grant covering 4,884 underlying shares (derivative/option). Each grant was recorded at $0.00 per share (no cash paid by the insider) for a total immediate value of $0 on the Form 4 filing.
Key Details
- Transaction date(s): February 25, 2026. Form 4 filed February 27, 2026 (appears timely).
- Grant details and prices: 997 RSUs @ $0.00; 4,884 derivative/option shares @ $0.00; total reported immediate value $0.
- Vesting: Both awards vest in four equal annual installments, with the first installment vesting on February 25, 2027, subject to continued service (see footnotes F1 and F2).
- F1 (RSUs): Convert to common stock 1-for-1 upon vesting.
- F2 (options/derivative): Underlying shares vest and become exercisable in four equal annual installments beginning 2/25/2027.
- Shares owned after transaction: Not specified in the provided excerpt of the filing.
- Filing timeliness: Filing date two days after the grants; no late-filing indicator shown.
Context
- These are compensation grants (awards), not open-market purchases or sales. RSUs and option grants are commonly used to retain and incentivize executives and do not reflect an immediate buy or sell decision by the insider. Vesting over four years means the economic benefit depends on continued employment and future vesting/exercise events.
Insider Transaction Report
Form 4
Carpio Robert L III
SVP Waters Analytical Sciences
Transactions
- Award
Common Stock
[F1]2026-02-25+997→ 3,615 total - Award
Stock Option (Right to Buy)
[F2]2026-02-25+4,884→ 4,884 totalExercise: $319.44Exp: 2036-02-25→ Common Stock (4,884 underlying)
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs"), which will vest in four equal annual installments, with the first such installment vesting on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date. The RSUs are convertible into shares of the Issuer's common stock on a one-to-one basis upon vesting and settlement.
- [F2]The shares of common stock underlying this stock option will vest and become exercisable in four equal annual installments, with the first such installment vesting and becoming exercisable on February 25, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
Signature
/s/ Michael Lynn, attorney-in-fact for Robert L. Carpio III|2026-02-27